The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

INTRODUCTION: Sodium-glucose co-transporter 2 inhibitors (SGLT-2i) increase urinary glucose excretion through a reduced renal glucose reabsorption. We plan to perform a systematic review of SGLT-2i for treatment of type 2 diabetes. METHODS AND ANALYSIS: A systematic review with meta-analyses of rand...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Storgaard, Heidi, Gluud, Lise Lotte, Christensen, Mikkel, Knop, Filip Krag, Vilsbøll, Tina
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2014
Témata:
Diabetes and Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139650/
https://ncbi.nlm.nih.gov/pubmed/25232561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005378
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky